vaborbactam
Sign in to saveVaborbactam (INN) is a non-β-lactam β-lactamase inhibitor discovered by Rempex Pharmaceuticals, a subsidiary of The Medicines Company. While not effective as an antibiotic by itself, it restores potency to existing antibiotics by inhibiting the β-lactamase enzymes that would otherwise degrade them. When combined with an appropriate antibiotic it can be used for the treatment of gram-negative bacterial infections.
~5 min read
Encyclopedic overview
2 sectionsContents
- Biochemistry
- References
{{Infobox drug | image = Vaborbactam.svg | image_class = skin-invert-image | width = 250 | alt = | caption =
| pronounce = | tradename = | Drugs.com = | MedlinePlus = | DailyMedID = | pregnancy_AU = | pregnancy_AU_comment = | pregnancy_category = | routes_of_administration = | class = | ATCvet = | ATC_prefix = None | ATC_suffix = | ATC_supplemental =
Excerpted from Wikipedia’s “vaborbactam” article, available under the CC BY-SA 4.0 licence.